Clinical Trials Directory

Trials / Completed

CompletedNCT00269230

Attain StarFix™ Model 4195 Left Ventricular Lead

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
441 (actual)
Sponsor
Medtronic Cardiac Rhythm and Heart Failure · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

People who have abnormal heart beats, or whose heart does not beat on its own, may need an electronic device called a pacemaker or a defibrillator. Furthermore, people whose hearts have a reduced pumping ability may need a device are called cardiac resynchronization therapy (CRT) device. A CRT device is implanted surgically just under the skin in the upper chest area. This device then helps the heart beat at a regular rhythm by sending electrical signals (pacing) directly to the heart tissue through flexible wires called leads. The device may also be able to stop the heart from beating too fast. Three leads are implanted into the chambers of your heart. Two of the leads will be placed on the right side of your heart. The third lead is placed on the left side of your heart and is the lead being studied. The purpose of this study is to evaluate the safety and efficacy of the Attain StarFixTM Model 4195 Left Ventricular (LV) Lead. This particular model lead has special characteristics that may help to better keep it in position once it is implanted into the left ventricle. It is also "steroid-eluting" which means that over time it slowly releases a small amount of medication into the heart tissue to help prevent too much swelling around the area it is implanted.

Conditions

Interventions

TypeNameDescription
DEVICEPacing LeadLeft ventricular pacing lead

Timeline

Start date
2004-07-01
Primary completion
2005-07-01
Completion
2005-07-01
First posted
2005-12-23
Last updated
2008-11-20

Locations

25 sites across 3 countries: United States, Canada, Italy

Source: ClinicalTrials.gov record NCT00269230. Inclusion in this directory is not an endorsement.